Litigation Details for Celgene Corporation v. Teva Pharmaceuticals USA, Inc. (D. Del. 2015)
✉ Email this page to a colleague
Celgene Corporation v. Teva Pharmaceuticals USA, Inc. (D. Del. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-12-09 |
| Court | District Court, D. Delaware | Date Terminated | 2016-08-08 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Patents | 7,608,280; 7,611,724 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Celgene Corporation v. Teva Pharmaceuticals USA, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Celgene Corporation v. Teva Pharmaceuticals USA, Inc. (D. Del. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-12-09 | 1 | United States Patent Nos. 7,608,280 (the “’280 patent”) and 7,611,724 (the “’724 patent”) (collectively… This is an action for patent infringement under the patent laws of the United States, 35 U.S.C… THE PATENTS-IN-SUIT 8. On October 27, 2009, the United States Patent and Trademark…lawfully issued the ’280 patent, titled “Method of Producing FR901228.” The ’280 patent is assigned to Astellas…United States Patent and Trademark Office (“USPTO”) duly and lawfully issued the ’724 patent, titled “Method | External link to document | |
| 2016-08-09 | 25 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,608,280 B2; 7,611,724 B2. (…2015 8 August 2016 1:15-cv-01143 830 Patent None District Court, D. Delaware | External link to document | |
| 2015-12-09 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,608,280 B2; 7,611,724 B2. (…2015 8 August 2016 1:15-cv-01143 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
